Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel antibacterial agents from Pharmacia & Upjohn

July 12, 1996

Erythromycin derivatives useful for infection treatment

July 12, 1996

U-94901: A powerful antibacterial agent from Pharmacia & Upjohn

July 12, 1996

OncorPharm acquires rights to dithymidine-based products

July 12, 1996

ProCyte seeks FDA marketing clearance for OsmoCyte

July 12, 1996

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Faulding's Kadian approved by FDA

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Low-estrogen oral contraceptives have low stroke risk

July 5, 1996

Oral contraceptive displays cardioprotective effects

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....